KABAN, S.M. et al. 2025. The Relationship between SLC22A16 Gene Polymorphism and Hematological Toxicity in Breast Cancer Patients Receiving Doxorubicin-Based Chemotherapy. Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI). 7, 1 (Feb. 2025), 27–33. DOI:https://doi.org/10.32734/jetromi.v7i1.18520.